ArticleEuropean journal of medicinal chemistry2019

Neutral sphingomyelinase 2 inhibitors based on the 4-(1H-imidazol-2-yl)-2,6-dialkoxyphenol scaffold.

Ondrej Stepanek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.